metricas
covid
Neurology perspectives Retrospective, multi-centre, open-label study on the use of alemtuzumab for rela...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Retrospective, multi-centre, open-label study on the use of alemtuzumab for relapsing–remitting multiple sclerosis in clinical practice: A 4-year follow-up
Estudio abierto retrospectivo multicéntrico sobre la utilización de alemtuzumab en esclerosis múltiple remitente-recurrente en práctica clínica habitual. Seguimiento durante 4 años
A. Pato-Patoa,
Corresponding author
apatopato@gmail.com

Corresponding author.
, P. Gabeiras-Araujoa, M. Lorenzo-Garcíab, C. Hernandez-Cerónc, J.R. Lorenzo-Gonzálezd, D.A. García-Estéveza
a Servicio de Neurología, Complexo Hospitalario Universitario de Ourense, Ourense, Spain
b Servicio de Neurología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
c Servicio de Medicina Interna, Complexo Hospitalario Universitario de Ourense, Ourense, Spain
d Servicio de Neurología, Hospital Povisa de Vigo, Vigo, Pontevedra, Spain
Read
1295
Times
was read the article
572
Total PDF
723
Total HTML
Share statistics
Article information
ISSN: 26670496
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 28 31 59
2025 11 152 223 375
2025 10 82 125 207
2025 9 65 50 115
2025 8 54 58 112
2025 7 103 21 124
2025 6 88 12 100
2025 5 64 14 78
2025 4 87 38 125

Follow this link to access the full text of the article